W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

X

communication

02 August, 2024

Communication – TLI effectiveness evaluation report

09 December, 2022

Communication – Acquisition of data to carry out the valuation of selected guaranteed dental treatment services

06 September, 2022

Communication – report on tariff setting for outpatient specialist care services: bone marrow aspiration biopsy, bone marrow trepanobiopsy, external consultations

19 August, 2022

Communication – new tariffs covering neonatal care

05 August, 2022

Communication – Data acquisition for gastroscopy performed in outpatient settings

20 July, 2022

Communication on the meeting of the Tariff Council on 14.07.2022

04 July, 2022

Communication on the meeting of the Tariff Council on 30 June 2022

29 June, 2022

Communication – acquisition of data Bone marrow biopsy (specialist outpatient care)

28 June, 2022

Communication on the meeting of the Tariff Council on 23 and 24 June 2022

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑